- This story is regularly updated for relevance. Last updated: May 24, 2021
Three days after the Johnson & Johnson COVID-19 vaccine was approved by the Federal Drug Administration, nearly 4 million doses will be distributed and available as soon as March 2. So, if you’re asking when you can get the Johnson & Johnson vaccine, the answer is this: right now.
Though the U.S. stopped giving the Johnson & Johnson vaccine on April 13 because of 13 instances of people developing potentially deadly blood clots after about 8 million people in the U.S. had received the vaccine, the temporary ban was lifted on April 23.
In mid-May, though, the Biden administration stopped shipping the vaccine because of domestic production issues, though that could only be a temporary decision. Soon after, it was reported that more than 100 million doses had been held up so inspectors could make sure they weren’t contaminated.
Still, people are free to get the Johnson & Johnson vaccine if they can find it, even though people are still developing blood clots in rare occurrences (according to CNN data, a person is 40 times more likely to die from COVID than they would be to die from blood clots caused by the vaccine).
In February, CDC Director Dr. Rochelle Walensky touted the vaccine’s benefits to encourage people to get inoculated against COVID-19. “As a one-dose vaccine, people do not have to return for a second dose to be protected. In addition, this vaccine does not need to be kept in a freezer and can be stored at refrigerated temperatures—so it is easy to transport and store and allows for expanded availability in most community settings and mobile sites, as supply scales up.”
As the Washington Post noted, the Johnson & Johnson vaccine’s reduced efficacy in preventing COVID-19 infection raises concerns that go beyond medical management. “Decisions to send the shots to harder-to-reach communities make practical sense, because Johnson & Johnson’s single-shot vaccine is easier to store and use. But they could drive perceptions of a two-tiered vaccine system, riven along racial or class lines—with marginalized communities getting what they think is an inferior product.”
The vaccine performed better on the variant first found in South Africa than originally thought. The Johnson & Johnson vaccine efficacy on that variant was 64%, seven percentage points higher than the original data showed (beginning in the summer of 2021, Johnson & Johnson will start phase 1 of trials for the vaccine that targets the variant).
In the U.S., the vaccine’s efficacy rate is 72%, and worldwide, the efficacy rate after 30 days is 66%.
The Pfizer and Moderna vaccines both have efficacy of at least 94%. But Vox made a point in Johnson & Johnson’s favor in its March 1 article declaring it a “game-changer.”
“From a practical standpoint,” that article noted, “it means that the new vaccine could really speed up America’s vaccination campaign—certainly more than another two-dose vaccine would. It also fixes a problem that’s long bedeviled medical treatments that require multiple doses: A lot of patients tend to drop off after the first appointment.”
The article also termed the 66% number the wrong number to look at when considering its effectiveness in slowing and mitigating a pandemic that has taken more than 565,000 American lives.
“The vaccine’s effectiveness at preventing people from getting sick with symptoms is arguably much less important than the vaccine’s effectiveness against hospitalization and death,” the Vox article argued. “And there is the promising news: In trials, the Johnson & Johnson vaccine brings both of those down to zero. It squashes the biggest thing that made COVID-19 so threatening to people: Its ability to kill.”
NBC News noted that although the rollout will be almost immediate, it will also be “uneven” throughout the month, with a goal of 20 million doses delivered by April 1 and a ramp-up to 100 million doses by summer (in late March, the company said it would hit that goal of 20 million). So while the Johnson & Johnson vaccine is available almost immediately, there still may be a question of when you can actually get it.
Especially since an April 1 New York Times report noted that 15 million doses had been compromised after plant workers in Baltimore mixed up the vaccine’s ingredients. That will delay the number of doses that would have gone out in April.
Dr. Anthony Fauci, labeling all three available vaccines as “highly efficacious,” touted the Johnson & Johnson vaccine as a suitable option for people who want to protect themselves against COVID-19 and have not gotten a vaccination.
“If you go to a place and you have J&J and that’s the one that’s available now, I would take it,” Fauci advised. “I personally would do the same thing. I think people need to get vaccinated as quickly and as expeditiously as possible.”
Read more on the coronavirus vaccine:
- Why are so many military members refusing to take the COVID vaccine?
- Will COVID vaccines be mandatory for you to go on cruises?
- These companies are actually paying their employees to get the COVID vaccine
- An ER doc takes us inside her COVID-19 vaccination experience—and assuages our fears
- How companies have turned to blockchain to respond to the COVID ‘data crisis’
- If you have these COVID vaccine side effects, Fauci says it’s actually good news
- Could the COVID-19 vaccine shot eventually be replaced by a pill?
- Does the Pfizer vaccine work against the COVID variants?
- Does the Moderna vaccine work against the new COVID-19 variants?
- Will the Johnson & Johnson vaccine be as effective as Pfizer and Moderna?
- How long will the COVID-19 vaccines keep you safe from the coronavirus?
- Can you drink alcohol after getting the coronavirus vaccine?